Given the rarity of loss-of-function germline RAD51B variants, our study had limited statistical power to assess an association between RAD51B inactivation and hormone receptor status among breast cancer cases, and additional cases will be required to confirm the association. This evidence concerns the gene NR4A1 and breast carcinoma.